Lilienfeld S

References (5)

Title : Sleep-related outcomes in persons with mild to moderate Alzheimer disease in a placebo-controlled trial of galantamine - Markowitz_2003_Sleep_26_602
Author(s) : Markowitz JS , Gutterman EM , Lilienfeld S , Papadopoulos G
Ref : Sleep , 26 :602 , 2003
Abstract :
PubMedSearch : Markowitz_2003_Sleep_26_602
PubMedID: 12938815

Title : An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia - Erkinjuntti_2003_Clin.Ther_25_1765
Author(s) : Erkinjuntti T , Kurz A , Small GW , Bullock R , Lilienfeld S , Damaraju CV
Ref : Clin Ther , 25 :1765 , 2003
Abstract :
PubMedSearch : Erkinjuntti_2003_Clin.Ther_25_1765
PubMedID: 12860497

Title : Galantamine - a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease - Lilienfeld_2002_CNS.Drug.Rev_8_159
Author(s) : Lilienfeld S
Ref : CNS Drug Rev , 8 :159 , 2002
Abstract :
PubMedSearch : Lilienfeld_2002_CNS.Drug.Rev_8_159
PubMedID: 12177686

Title : Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial - Erkinjuntti_2002_Lancet_359_1283
Author(s) : Erkinjuntti T , Kurz A , Gauthier S , Bullock R , Lilienfeld S , Damaraju CV
Ref : Lancet , 359 :1283 , 2002
Abstract :
PubMedSearch : Erkinjuntti_2002_Lancet_359_1283
PubMedID: 11965273

Title : A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group - Tariot_2000_Neurology_54_2269
Author(s) : Tariot PN , Solomon PR , Morris JC , Kershaw P , Lilienfeld S , Ding C
Ref : Neurology , 54 :2269 , 2000
Abstract :
PubMedSearch : Tariot_2000_Neurology_54_2269
PubMedID: 10881251